Business
OWC Pharmaceuticals Corp to Present at Israeli Advanced Technology Industry's BioMed Conference
OWC Pharmaceuticals Corp to Present at Israeli Advanced Technology Industry's BioMed Conference.
About this update from Owc Pharmaceutical Research Corp
[{"type":"text","content":"\n\n\n\nOWC Pharmaceuticals Corp to Present at Israeli Advanced Technology Industry's BioMed Conference\n\n\n\n\n\nOWC Pharmaceuticals Corp to Present at Israeli Advanced Technology Industry's BioMed Conference\nSelected To Present at the Start-ups Hall Booth #80\nPR Newswire\nPETACH TIKVA, Israel, April 26, 2016\n\n\n\nPETACH TIKVA, Israel, April 26, 2016 /PRNewswire/ --\n\n \n\nOWC Pharmaceutical Research Corp. (OTCQB: OWCP), (\"OWC\" or the \"Company\"), an Israeli-based developer of cannabinoid-based therapies targeting a variety of different indications, today announced that it was selected to present at the 2016 Israeli Advanced Technology Industries (IATI) BioMed Conference (the \"Conference\").\n\n     (Logo: http://photos.prnewswire.com/prnh/20150311/734965-a )\n\n\n     (Logo: http://photos.prnewswire.com/prnh/20150311/734965-b )\n\n\nThe Conference is a part of Israel's 15th National Life Sciences and Technology Week, and is being held May 24th to 26th at the David Intercontinental Hotel in Tel Aviv, Israel. The Company is currently scheduled to present at Booth #80 on the 24th .\n\nThe Biomed conference is the preeminent event for the Israeli life sciences industry, attracting leading members of the healthcare industry from around the globe. It comprises group discussions, panel presentations, product demonstrations and networking opportunities, all designed to encourage business collaborations. Attendees are able to experience firsthand the entrepreneurial spirit which is a basis of Israel's vibrant life sciences community. Prior conferences have hosted over 6,000 industry senior executives, scientists, and engineers, including approximately 1,000 participants from over 45 countries and in excess of 4,500 one-on-one meetings.\n\nZiv Turner, OWC Israel CEO stated, \"We are so proud to have been selected by IATI to participate in BioMed. This is the biggest and most established annual meeting of the Israeli life science industry. The conference attracts investors and companies from around the world who are looking for innovation and ground breaking technology, providing us with the opportunity to meet one on one with potential investors, strategic partners and collaborators.\"\n\nAbout OWC Pharmaceutical Research Corp.    \n\nOWC Pharmaceutical Research Corp., thr...